Cargando…

Dual Targeting of MEK and PI3K Pathways Attenuates Established and Progressive Pulmonary Fibrosis

Pulmonary fibrosis is often triggered by an epithelial injury resulting in the formation of fibrotic lesions in the lung, which progress to impair gas exchange and ultimately cause death. Recent clinical trials using drugs that target either inflammation or a specific molecule have failed, suggestin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madala, Satish K., Edukulla, Ramakrishna, Phatak, Mukta, Schmidt, Stephanie, Davidson, Cynthia, Acciani, Thomas H., Korfhagen, Thomas R., Medvedovic, Mario, LeCras, Timothy D., Wagner, Kimberly, Hardie, William D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903543/ https://www.ncbi.nlm.nih.gov/pubmed/24475138 http://dx.doi.org/10.1371/journal.pone.0086536

Ejemplares similares

Resistin-like molecule alpha1 (Fizz1) recruits lung dendritic cells without causing pulmonary fibrosis
por: Madala, Satish K, et al.
Publicado: (2012)

IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function
por: Singh, Brijendra, et al.
Publicado: (2016)

Correction: IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function
por: Singh, Brijendra, et al.
Publicado: (2017)

Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer
por: Blas, Kevin, et al.
Publicado: (2018)

Rapamycin Regulates Bleomycin-Induced Lung Damage in SP-C-Deficient Mice
por: Madala, Satish K., et al.
Publicado: (2011)

Genome-Wide Signatures of Transcription Factor Activity: Connecting Transcription Factors, Disease, and Small Molecules
por: Chen, Jing, et al.
Publicado: (2013)

Novel Roles of the Picornaviral 3D Polymerase in Viral Pathogenesis
por: Kerkvliet, Jason, et al.
Publicado: (2010)

Alternative dosing of dual PI3K and MEK inhibition in cancer therapy
por: Jokinen, Elina, et al.
Publicado: (2012)

Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers
por: Temraz, Sally, et al.
Publicado: (2015)

Genomics Portals: integrative web-platform for mining genomics data
por: Shinde, Kaustubh, et al.
Publicado: (2010)

New features in MEK retinopathy
por: Tyagi, Pallavi, et al.
Publicado: (2018)

The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition
por: Haagensen, E J, et al.
Publicado: (2012)

Dual inhibition of the MEK/ERK and PI3K/AKT pathways prevents pulmonary GVHD suppressing perivenulitis and bronchiolitis
por: Muranushi, Hiroyuki, et al.
Publicado: (2022)

Differential Effects of Rapamycin and Dexamethasone in Mouse Models of Established Allergic Asthma
por: Mushaben, Elizabeth M., et al.
Publicado: (2013)

Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037
por: Haagensen, Emma J., et al.
Publicado: (2016)

Mek1 and Mek2 Functional Redundancy in Erythropoiesis
por: Beuret, Laurent, et al.
Publicado: (2021)

Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer
por: Toulany, Mahmoud, et al.
Publicado: (2016)

3123 TGFbeta, Early Cytokine Dysregulation, and Airway Smooth Muscle Dysfunction in Cystic Fibrosis
por: Kramer, Elizabeth L, et al.
Publicado: (2019)

Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies
por: Kuracha, Murali R., et al.
Publicado: (2017)

Repression of CD24 surface protein expression by oncogenic Ras is relieved by inhibition of Raf but not MEK or PI3K
por: Pallegar, Nikitha K., et al.
Publicado: (2015)

Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells
por: Jin, W, et al.
Publicado: (2003)

Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy
por: Chang, Raymond, et al.
Publicado: (2019)

Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
por: Du, Wei, et al.
Publicado: (2021)

K-RAS Mutant Pancreatic Tumors Show Higher Sensitivity to MEK than to PI3K Inhibition In Vivo
por: Hofmann, Irmgard, et al.
Publicado: (2012)

Establishment of a novel method to assess MEK1/2 inhibition in PBMCs for clinical drug development
por: Schüssele, Lara M., et al.
Publicado: (2022)

Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells()
por: Wu, Y. Linda, et al.
Publicado: (2017)

ASK1ng to Delay the Progression of Pulmonary Fibrosis
por: Schuliga, Michael, et al.
Publicado: (2022)

Searching for an Animal Model with Clinical Features of Scleroderma
por: Vliagoftis, Harissios, et al.
Publicado: (2023)

Scrambled or flipped: 5 facts about how cellular phosphatidylserine localization can mediate viral replication
por: Acciani, Marissa Danielle, et al.
Publicado: (2022)

PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors
por: Schmidt, Enrico K, et al.
Publicado: (2004)

Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells
por: Yuen, Hiu-Fung, et al.
Publicado: (2012)

Synergistic Effects of Concurrent Blockade of PI3K and MEK Pathways in Pancreatic Cancer Preclinical Models
por: Zhong, Hua, et al.
Publicado: (2013)

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
por: Haas, Bodo, et al.
Publicado: (2018)

Combined MEK and Pi3′-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo
por: ElMokh, Oussama, et al.
Publicado: (2017)

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
por: Li, Qingfang, et al.
Publicado: (2022)

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
por: Fattore, Luigi, et al.
Publicado: (2015)

Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling
por: Fish, Jason E., et al.
Publicado: (2020)

DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer Properties
por: Goulielmaki, Maria, et al.
Publicado: (2019)

Notch3: A New Culprit in Fibrotic Lung Disease
por: Gajjala, Prathibha R., et al.
Publicado: (2021)

Lung Fibrosis Finds an Unsung Hero in Neuropeptide Y
por: Madala, Satish K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m7n9fn3esutgmgskj0c1ttda09